ArticleThe oncologist2018

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

Mariette Labots et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.